Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1986 Jun 1;163(6):1509–1517. doi: 10.1084/jem.163.6.1509

Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep

PMCID: PMC2188117  PMID: 3011947

Abstract

We examined changes in the levels of eicosanoids in blood and pulmonary lymph of anesthetized sheep undergoing acute anaphylaxis. Within 1-3 min of intravenous antigenic challenge of previously sensitized sheep, there were approximately 7-30-fold elevations in mean arterial plasma levels of thromboxane B2 and 6-ketoprostaglandin F1 alpha, respectively, as measured by RIA. Negligible changes in levels of these cyclooxygenase products were found in both nonsensitized sheep and in sensitized sheep treated with indomethacin before antigenic challenge. In contrast, no changes in levels of sulfidopeptide leukotrienes (SPLT) in pulmonary lymph were detectable by RIA during anaphylaxis in sensitized or nonsensitized sheep, but levels of SPLT in indomethacin- treated sensitized sheep increased more than fivefold above levels in lymph from both other groups of animals. The immunoreactive SPLT in lymph from indomethacin-treated sheep was accounted for as LTE4, as demonstrated by mobility on HPLC and absorbance at 280 nm. These results support the possibility that certain undesirable effects of nonsteroidal antiinflammatory drugs, such as cardiopulmonary reactions in aspirin-sensitive individuals, and impaired renal and cardiac function during therapy with these drugs, may be related in part to augmented synthesis of the 5-lipoxygenase pathway products, especially those of the sulfidopeptide class. Increased LT production could also limit the antiinflammatory effectiveness of these drugs in many disease states.

Full Text

The Full Text of this article is available as a PDF (557.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. K., 3rd, Lichtenstein L. M. Indomethacin enhances response of human bronchus to antigen. Am Rev Respir Dis. 1985 Jan;131(1):8–10. doi: 10.1164/arrd.1985.131.1.8. [DOI] [PubMed] [Google Scholar]
  2. Axelrod L., Levine L. Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis. Diabetes. 1982 Nov;31(11):994–1001. doi: 10.2337/diacare.31.11.994. [DOI] [PubMed] [Google Scholar]
  3. Burka J. F., Paterson N. A. Evidence for lipoxygenase pathway involvement in allergic tracheal contraction. Prostaglandins. 1980 Apr;19(4):499–515. doi: 10.1016/s0090-6980(80)80001-3. [DOI] [PubMed] [Google Scholar]
  4. Chun P. K., Gertz E., Davia J. E., Cheitlin M. D. Coronary atherosclerosis in mitral stenosis. Chest. 1982 Jan;81(1):36–41. doi: 10.1378/chest.81.1.36. [DOI] [PubMed] [Google Scholar]
  5. Coles S. J., Neill K. H., Reid L. M., Austen K. F., Nii Y., Corey E. J., Lewis R. A. Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins. 1983 Feb;25(2):155–170. doi: 10.1016/0090-6980(83)90101-6. [DOI] [PubMed] [Google Scholar]
  6. Creticos P. S., Peters S. P., Adkinson N. F., Jr, Naclerio R. M., Hayes E. C., Norman P. S., Lichtenstein L. M. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21;310(25):1626–1630. doi: 10.1056/NEJM198406213102502. [DOI] [PubMed] [Google Scholar]
  7. Dahlén S. E., Hansson G., Hedqvist P., Björck T., Granström E., Dahlén B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1712–1716. doi: 10.1073/pnas.80.6.1712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drazen J. M., Austen K. F., Lewis R. A., Clark D. A., Goto G., Marfat A., Corey E. J. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4354–4358. doi: 10.1073/pnas.77.7.4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Drazen J. M., Venugopalan C. S., Austen K. F., Brion F., Corey E. J. Effects of leukotriene E on pulmonary mechanics in the guinea pig. Am Rev Respir Dis. 1982 Mar;125(3):290–294. doi: 10.1164/arrd.1982.125.3.290. [DOI] [PubMed] [Google Scholar]
  10. Feuerstein G. Leukotrienes and the cardiovascular system. Prostaglandins. 1984 May;27(5):781–802. doi: 10.1016/0090-6980(84)90015-7. [DOI] [PubMed] [Google Scholar]
  11. Ham E. A., Soderman D. D., Zanetti M. E., Dougherty H. W., McCauley E., Kuehl F. A., Jr Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4349–4353. doi: 10.1073/pnas.80.14.4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hamberg M., Svensson J., Samuelsson B. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc Natl Acad Sci U S A. 1974 Oct;71(10):3824–3828. doi: 10.1073/pnas.71.10.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harper T. W., Westcott J. Y., Voelkel N., Murphy R. C. Metabolism of leukotrienes B4 and C4 in the isolated perfused rat lung. J Biol Chem. 1984 Dec 10;259(23):14437–14440. [PubMed] [Google Scholar]
  14. Kadowitz P. J., Hyman A. L. Analysis of responses to leukotriene D4 in the pulmonary vascular bed. Circ Res. 1984 Nov;55(5):707–717. doi: 10.1161/01.res.55.5.707. [DOI] [PubMed] [Google Scholar]
  15. Lee C. W., Lewis R. A., Corey E. J., Barton A., Oh H., Tauber A. I., Austen K. F. Oxidative inactivation of leukotriene C4 by stimulated human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4166–4170. doi: 10.1073/pnas.79.13.4166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Levine L., Alam I. Arachidonic acid metabolism by cells in culture: analyses of culture fluids for cyclooxygenase products by radioimmunoassay before and after separation by high pressure liquid chromatography. Prostaglandins Med. 1979 Nov;3(5):295–304. doi: 10.1016/0161-4630(79)90071-5. [DOI] [PubMed] [Google Scholar]
  17. Lewis R. A., Austen K. F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lewis R. A. Leukotrienes and other lipid mediators of asthma. Chest. 1985 Jan;87(1 Suppl):5S–10S. doi: 10.1378/chest.87.1.5s. [DOI] [PubMed] [Google Scholar]
  19. McManus L. M., Shaw J. O., Pinckard R. N. Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit. J Immunol. 1980 Nov;125(5):1950–1954. [PubMed] [Google Scholar]
  20. Michelassi F., Landa L., Hill R. D., Lowenstein E., Watkins W. D., Petkau A. J., Zapol W. M. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science. 1982 Aug 27;217(4562):841–843. doi: 10.1126/science.6808665. [DOI] [PubMed] [Google Scholar]
  21. Pfeffer M. A., Pfeffer J. M., Lewis R. A., Braunwald E., Corey E. J., Austen K. F. Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. Am J Physiol. 1983 Apr;244(4):H628–H633. doi: 10.1152/ajpheart.1983.244.4.H628. [DOI] [PubMed] [Google Scholar]
  22. Piper P. J., Stanton A. W., McLeod L. J. The actions of leukotrienes C4 and D4 in the porcine renal vascular bed. Prostaglandins. 1985 Jan;29(1):61–73. doi: 10.1016/0090-6980(85)90151-0. [DOI] [PubMed] [Google Scholar]
  23. Rokach J., Hayes E. C., Girard Y., Lombardo D. L., Maycock A. L., Rosenthal A. S., Young R. N., Zamboni R., Zweerink H. J. The development of sensitive and specific radioimmunoassays for leukotrienes. Prostaglandins Leukot Med. 1984 Jan;13(1):21–25. doi: 10.1016/0262-1746(84)90098-2. [DOI] [PubMed] [Google Scholar]
  24. Salmon J. A., Simmons P. M., Moncada S. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol. 1983 Dec;35(12):808–813. doi: 10.1111/j.2042-7158.1983.tb02901.x. [DOI] [PubMed] [Google Scholar]
  25. Vanderhoek J. Y., Bailey J. M. Activation of a 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen. J Biol Chem. 1984 Jun 10;259(11):6752–6756. [PubMed] [Google Scholar]
  26. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES